Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Can you guess the (lightly disputed) champion of healthcare AI suppliers? Here’s a hint. This company caters to physicians and just this week reached a valuation of $12B.
UnitedHealth Group CEO Stephen Hemsley is expected to make the announcement in front of Congress, where he will also offer other policy solutions. The company said it’s still working out details on how to best distribute its profits to customers.
Extravascular ICDs were developed to avoid complications such as vascular injuries, lead fractures and lead infections. Although rare, these issues can cause serious, life-threatening complications for patients.
The insurer is planning to reduce reimbursement timelines for hospitals in Oklahoma, Idaho, Minnesota and Missouri from 30 days to 15. The details are unclear, but the company said the framework could extend nationwide.
The past 12 months have brought numerous exciting advances involving AI and related emerging technologies. Let us not fail to take a short last look at some of the more spectacular flops.
Some investment analysts are predicting a more permissive M&A market, deregulation as a catalyst for growth and fiscal policies that stimulate economic activity. And they see AI as a catalyst in the shift.